Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Subdural hematoma

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44346   clinical trials with a EudraCT protocol, of which   7374   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    10 result(s) found for: Subdural hematoma. Displaying page 1 of 1.
    EudraCT Number: 2015-000927-96 Sponsor Protocol Number: SUCRE Start Date*: 2015-08-04
    Sponsor Name:CHU of Rennes
    Full Title: Treatment of chronic subdural hematoma by corticosteroids : a prospective randomized study
    Medical condition: chronic subdural hematoma
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004863 10049163 Chronic subdural hematoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2011-003544-42 Sponsor Protocol Number: 2011-3 Start Date*: 2012-02-16
    Sponsor Name:Department of Neurosurgery, PMU
    Full Title: DRES - A prospective, multi-center, double blind, randomized, placebo controlled study to assess the efficacy of Dexamethason in reducing the reoperation rate in patients with chronic subdural hema...
    Medical condition: operated chronic subdural hematoma
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004863 10049163 Chronic subdural hematoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000247-34 Sponsor Protocol Number: COXIBRAIN I Start Date*: 2008-09-26
    Sponsor Name:Charité – Universitätsmedizin Berlin
    Full Title: Prospektive randomisierte Phase II/III-Studie zur selektiven COX-2-Inhibition beim chronischen Subduralhämatom (Prospective randomized phase II/III study for the selective COX-2-inhibition in chron...
    Medical condition: chronic subdural haematoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10049162 Chronic subdural haematoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-004948-35 Sponsor Protocol Number: Dex-CSDH Start Date*: 2015-03-20
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
    Full Title: A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma.
    Medical condition: chronic subdural haematoma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10022117 - Injury, poisoning and procedural complications 10042361 Subdural haematoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-001563-39 Sponsor Protocol Number: DENISH2015 Start Date*: 2016-05-20
    Sponsor Name:Medical Centre Haaglanden (MCH) [...]
    1. Medical Centre Haaglanden (MCH)
    2. Medical Centre Haaglanden (MCH)
    Full Title: Dexamethasone (DXM) therapy in symptomatic patients with chronic subdural hematoma (DECSA– Trial). Effect of initial corticosteroid therapy versus primary surgery on clinical outcome.
    Medical condition: Chronic subdural hematoma.
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004863 10049163 Chronic subdural hematoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-004311-40 Sponsor Protocol Number: TORCH Start Date*: 2018-05-24
    Sponsor Name:Academic Medical Center
    Full Title: Tranexamic Acid to Prevent Operation in Chronic Subdural Hematoma
    Medical condition: Chronic Subdural Hematoma
    Disease: Version SOC Term Classification Code Term Level
    20.1 10022117 - Injury, poisoning and procedural complications 10049163 Chronic subdural hematoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2019-002075-33 Sponsor Protocol Number: ENRICH-AF Start Date*: 2020-05-05
    Sponsor Name:Hamilton Health Sciences, through its Population Health Research Institute
    Full Title: Edoxaban for intracranial hemorrhage survivors with atrial fibrillation
    Medical condition: High risk atrial fibrillation patients with previous intracranial hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10018985 Haemorrhage intracranial PT
    20.0 10007541 - Cardiac disorders 10003658 Atrial fibrillation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA) NO (Prematurely Ended) DE (Trial now transitioned) ES (Ongoing) PT (Trial now transitioned) BE (Trial now transitioned) CZ (Trial now transitioned) AT (Trial now transitioned) IT (Trial now transitioned) SK (Trial now transitioned) DK (Trial now transitioned) GR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2008-005653-37 Sponsor Protocol Number: ICH-VKA Start Date*: 2009-05-29
    Sponsor Name:Universityhospital of Heidelberg
    Full Title: Multicenter, prospective randomized trial on the use of prothrombin complex and fresh frozen plasma in patients with intracerebral hemorrhage related to vitamin K antagonists (VKA)
    Medical condition: Intracerebral hemorrhage (ICH) in patients related to vitamin K antagonists
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10022754 Intracerebral hemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Suspended by CA) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2018-002620-17 Sponsor Protocol Number: 18-513 Start Date*: 2019-01-08
    Sponsor Name:Portola Pharmaceuticals, Inc
    Full Title: A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA [ANDEXANET ALFA FOR INJECTION] IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR
    Medical condition: Oral FXa inhibitor-treated patients with acute intracranial bleeding.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10075279 Anticoagulant reversal therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) BE (Completed) NL (Completed) ES (Prematurely Ended) GR (Completed) CZ (Completed) LV (Completed) FI (Prematurely Ended) NO (Prematurely Ended) LT (Prematurely Ended) PL (Completed) PT (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-001515-10 Sponsor Protocol Number: KAR-031 Start Date*: 2022-12-12
    Sponsor Name:Karuna Therapeutics
    Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease Deme...
    Medical condition: Psychosis Associated with Alzheimer’s Disease Dementia
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10012271 Dementia Alzheimer's type PT
    20.0 100000004873 10037234 Psychosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) SK (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) BG (Trial now transitioned) DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Jun 24 16:07:38 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA